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We report a case of re-expansion pulmonary oedema (RPE) occurring after a mediastinal
tumour removal procedure. RPE is a rare complication associated with the treatment of a
collapsed lung caused by pneumothorax, pleural effusion or tumour. The risk factors are a
longer period (more than three days) of collapsed lungs, the volume of intrathoracic lesion,
loss of surfactant and the patient's age. Treatment of RPE is difﬁcult due to there being no
clear pathophysiology, and is associated with high mortality. Careful management and
clinical guidelines are needed to render the therapy more effective.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.1. Introduction
Re-expansion pulmonary oedema (RPE) was ﬁrst described by
Carlson in 1959. He reported that RPE occurred after the re-ex-
pansion of collapsed lungs caused by the pneumothorax
being treated with thoracocentesis. The RPE may be a rare
complication of evacuation of pleural effusion, mediastinal
tumour resection, removal of large extrathoracic lesions (e.g.
giant abdominal mass). Because of the associated high
mortality (about 21%), the most effective clinical approach
is identiﬁcation of the risk factors, careful management of the
patient and preventative assurance of the equipment needed
for treatment of this complication.2. Case
A 33-year-old man was admitted to our hospital and was
scheduled for mediastinal tumour resection. His medical
history was unremarkable. He had been having fatigue,
malaise and low-degree fever for three months and dyspnoeach Society of Cardiology.
; fax: +421 2 59320 416.
nková), emsten1@hotmafor the last month. A chest X-ray revealed a giant tumour
mass of the left hemithorax. CT examination showed a non-
homogeneous tumour mass ﬁlling the whole of the left hemi-
thorax (Figs. 1 and 2). The transparietal biopsy specimen
could not determine the diagnosis: it showed necrotic tissue,
old organised haematoma, the lung tissue was not present;
immunohistochemical analysis did not conﬁrm the malig-
nant tumour. Tumour removal was recommended in our hos-
pital, with the cooperation of cardiac and thoracic surgeons.
At the time of admission, the patient's pulmonary function
studies revealed a severe restrictive ventilatory defect, but his
haemoglobin saturation was 99% (room air). Laboratory tests
showed mild normocytic anaemia (RBC 3.72 T/l, Hgb 95 g/l, Hct
0.309, MCV 83.1 ﬂ), kidney function tests were normal, liver tests,
except for a higher level of gamma glutamyltransferase, were
also in the normal ranges. We found a low serum concentration
of iron, total cholesterol and elevated C-reactive protein and fer-
ritin level. INR was elevated (1.33), very high D-dimer levels were
detected as the indicator of haemostatic activation and ﬁbrino-
lysis. The ECG showed sinus tachycardia, without ischaemic
changes.Published by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
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Fig. 1 – CT examination showed a non-homogeneous tumour
mass ﬁlling the whole of the left hemithorax.
Fig. 2 – Giant tumour mass of the left hemithorax.
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usual projection was not possible. The massive tumour
caused a mediastinal shift with displacement of the heart
to the other side of the chest. There were no abnormalities
of the valves, no left ventricular hypertrophy with ejection
fraction 60%, the right atrium and ventricle were deformed
by tumour pressure.
His pre-operative blood pressure was 125/70mmHg, and
heart rate was 100 bpm. The operation was performed in the
supine position. After right subclavian vein cannulation, general
anaesthesia was induced with etomidate 20mg, esmeron 50mg
and midazolam 5mg IV. The patient was intubated and
mechanical ventilation was started in a pressure-controlled
mode. The surgery was initiated using extracorporeal circulation
(ECC) through cannulation of the femoral vessels; the basic
central venous pressure (CVP) was high at 20–23mmHg.
We performed a median sternotomy and found a giant retro-
sternal tumour ﬁlling the whole left hemithorax and deviating
themediastinum and their organs to the right. The tumourmasswas polycystic and of a ﬁrm consistency. We mobilised the
tumour and, due to the big volume (weight was 3,165 kg), we
made a left-side thoracotomy in the 4. intercostal space
(Clamshell). The tumour inﬁltrated the completely atelectatic
left lung. Partial resection of the tumour was not possible
because of inﬁltration of the surrounding tissues and hypervas-
cularisation. After preparation, the whole tumour was removed
5 h after surgery had started. During this period, we made
precise haemostasis of nutrition vessels with double ligation,
the amount of blood transfused was 550ml, haemoﬁltration by
ECC 2450ml, the CVP was 16–17mmHg, and the left lung
became expanded. When ECC was stopped, the patient's blood
pressure was low: 80/40mmHg; we detected extensive diffuse
bleeding. Locally and IV haemostasis was started, blood transfu-
sion (2500ml). We made a revision of the surgical wound
without identiﬁcation of the source of bleeding. We continued
treating for circulatory shock, pharmacological resuscitation
with vasopressors (noradrenalin, adrenalin), administration
of haemostyptic therapy (antitrombin, protaminsulphat, terli-
pressin, plasma, acidum 4-aminomethylbenzoicum, acidum
tranexamicum, etamsylatum, phytomenadionum) and hydro-
cortisone. Despite maximal intensive care, three hours later we
terminated the resuscitation; the patient died as “mors in
tabula”.
Histology conﬁrmed a teratoma with mature and imma-
ture components accompanied by residual semi-nomatous
tumour cell. The other pathological diagnoses after section
were brain oedema, bilaterally ﬂuidothorax and pulmonary
oedema, pulmonary parenchymal and subpleural bleeding.
Our suspicion was that the direct cause of death was a re-
expansion pulmonary oedema following removal of a giant
mediastinal tumour and haemostasis activation with ﬁbrino-
lysis and shock due to operative trauma.3. Discussion
RPE is a rare complication of the treatment of lung collapse
secondary to atelectasis, pleural effusion, pneumothorax
or mediastinal tumour and this complication generally
manifests early, following re-expansion [1,2]. Re-expansion
pulmonary oedema may also be related to: bronchial obstruc-
tion, application of excessive suction to the tracheobronchial
tree during bronchoscopy and/or suctioning with a tracheal
suction catheter, alteration of the pulmonary artery pressure,
removal of large extra-thoracic lesions [3]. The incidence of RPE
following pneumothorax and effusion is between 0% and 1% in
most studies. The British Thoracic Society guidelines suggest
−1.5 l pleural ﬂuid should be drained at a time. The condition is
associated with a high mortality (higher than 21%) [3].
The pathogenesis of re-expansion pulmonary oedema is
controversial because the causes are unclear and probably
multi-factorial. It can be uni-lobar or multi-lobar, depending
on the degree of pre-existing atelectasis. Younger patient age
is a risk factor in the development of RPE [1]. A relative lack of
surfactant has been suggested as a causative factor [4]. The
decrease in alveolar surfactant activity is said to induce
pulmonary oedema by lowering the intrapleural pressure
and powering the perivascular pressure of pulmonary micro-
vessels [5].
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neous rapid increase in blood ﬂow and concurrent alveolar
distention. This leads to increases in the pulmonary capillary
pressure, hydrostatic pressure and pressure-induced mechanical
alveolar-capillary disruption. The increased capillary permeabil-
ity and transudation of ﬂuid into the lung, overﬂow of ﬂuid and
protein contribute to the development of pulmonary oedema,
hypoxia and cardiac dysfunction [3]. This enhanced endothelial
permeability may then propagate and worsen as a result of the
local cellular delivery of free radicals (the main basis of reperfu-
sion injury) and inﬂammatory mediators. There are reports of
the superoxide dismutase and cytochrome oxidase of mitochon-
dria declining in a collapsed lung, but the mechanism of their
action is unclear [6]. Sohara points out that the oxygen-derived
free radicals and pulmonary microvascular injury induce leuco-
cyte sequestration into the lung which injure the pulmonary
microvessels, cause biological injuries and RPE. Nakamura
reported increased interleukin 8, leukotriene B4 and polymor-
phonuclear leucocyte elastasa levels in the sputum in lungs after
RPE [7]. Another potential factor in the pathogenesis of RPE is
increased hydrostatic pressure from vascular ﬂooding of the re-
expanded lung caused by negative intrapleural pressure [8,9].
Hydrostatic pressure elevation is probably associated with the
elevation of various selectin proteins (E-selectin, L- selectin, P-
selectin) [3].
The clinical presentation of re-expansion pulmonary
oedema can vary considerably, ranging from asymptomatic
radiological ﬁndings to a combination of severe cardiac and
respiratory insufﬁciency and circulatory shock. It is important
to detect the initial signs of unilateral pulmonary oedema early
in order to commence treatment and prevent the sequence
referred to above that can lead to severe respiratory failure and
death. The most common symptoms are dyspnoea, thoracic
pain and cough. Physical ﬁndings are cyanosis, rales on aus-
cultation, nausea, tachycardia, hypotension.
The radiological features are also variable: we can see X-rays
with Kerley's B lines, interstitial opacities or consolidation.
The symptoms may appear within the ﬁrst two hours after
RPE [10], but it may be delayed by 24–48 h [3].
The treatment of RPE is difﬁcult due to its unclear pathophy-
siology. However, there is no deﬁnitive treatment for this
condition in its severest forms. The most reliable method in
these cases is tracheal intubation and non-invasive positive
pressure ventilation. In the setting of refractory pulmonary
failure, different two-lung ventilatory strategies have been
described. Asynchronous differential lung ventilation is a rela-
tively new therapeutic modality for the pre-operative, intra-
operative, or post-operative treatment of respiratory failure
secondary to a ventilation-perfusion mismatch but is still con-
sidered controversial, especially if the patient is haemodynami-
cally unstable [11]. Hung et al. report a case of RPE when pulse
contour cardiac output monitoring using a single transpulmon-
ary thermal dilution technique was applied to achieve optimal
cardiac preload for organ perfusion and to prevent worsening of
the pulmonary oedema from ﬂuid overload. The other choice of
effective treatment according to Tung et al. is bilateral, develop-
ing re-expansion pulmonary oedema treated with extracorporeal
membrane oxygenation [12]. The other symptomatic therapy isthe administration of vasopressor and ionotropic agent, body
ﬂuid management with diuretics and hyperosmotic colloid
solution, glucocorticoids, bronchodilators [13].4. Conclusion
Pulmonary re-expansion oedema is a rare complication in
thoracic surgery. In severe cases the basic symptomatic
therapy is not effective. It is important for anaesthesiologists
to be aware of the possibility of circulatory collapse, respira-
tory impairment, and development of RPE during anaesthetic
management of a patient with a mediastinal tumour and
atelectasis. Guidelines are required for future management of
RPE during mediastinal tumour resection procedures.
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